MedTrace Logo

Digital and Behavioral Tele-Health Tapering Program for Lowering Dependence on Opioids in Patients Undergoing Surgery

NCT04963972 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 272

Last updated 2022-05-10

No results posted yet for this study

Summary

This clinical trial studies the effect of behavioral health support including tele-health in helping surgical patients taper off of prescription opioid pain medications. "Tapering off" means taking dose amounts of medication that get smaller over time, so that less and less of the drug is used until it is not needed anymore. Researchers want to learn how these techniques may improve a patient's ability to lower or avoid dependence on opioid medications after surgery, and if behavioral therapies may improve quality of life, emotional well-being, and functional status around surgery.

Conditions

  • Malignant Abdominal Neoplasm
  • Malignant Head and Neck Neoplasm
  • Malignant Solid Neoplasm
  • Malignant Thoracic Neoplasm

Interventions

BEHAVIORAL

Behavioral Intervention

Participate in Lucid Lane therapy program

OTHER

Best Practice

Receive standard of care opioid education

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • Lucid Lane, Inc

    lead INDUSTRY

Principal Investigators

  • Lakshmi Koyyalagunta · M.D. Anderson Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-23
Primary Completion
2023-02-01
Completion
2023-02-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04963972 on ClinicalTrials.gov